Learn more about our comprehensive legal services.
Advising our clients on different opportunities and challenges of the industry.
Developing a unique culture, which blends traditional client care with modern technology and working practices since 1851.
Stay up to date on the latest news and legal insights.
News & Insights
The Securities and Futures (Amendment) Bill 2013 was gazetted on 28 June 2013. It is currently being considered by the Legislative Council.
The Bill amends the Securities and Futures Ordinance (SFO) to create the framework for regulation of OTC derivatives in Hong Kong. The framework reflects the conclusions of the public consultation exercise, which were published in July 2012 (available here). The Bill also creates new regulated activities relating to OTC derivative transactions and sets out the transitional arrangements for persons who currently engage in OTC derivatives transactions in Hong Kong. Supplementary consultation conclusions giving guidance on the regulators' thinking about the scope of the new regulated activities and the transitional provisions contained in the Bill were published on 6 September 2013 and are available here.
In addition, the Bill:
Below are summaries of the Bill provisions relating to OTC derivatives and the transitional arrangements that will apply to existing licensed asset managers.
Summary of Bill provisions relating to OTC derivatives
The Bill:
Transitional arrangements – Considerations for asset managers
Type 9 regulated activity (asset management) will be expanded to include "OTC derivative products management", defined as "providing the service of managing a portfolio of OTC derivative products for another person".
Existing licensed asset managers will need to consider whether to:
A threshold question existing licensed asset managers will need to consider is whether they meet the experience requirements for the expanded type 9 RA and the new type 11 RA.
Applying for the expanded type 9 regulated activity
If an asset manager does not (and does not intend to) include OTC derivative products in the portfolios it manages, it does not need to apply for the expanded type 9 RA. If an asset manager does not apply for the expanded type 9 RA within the specified application period of 6 months from the commencement date for the expanded type 9 RA, its licence will be deemed subject to a condition that the asset manager must not carry on OTC derivative products management.
The definition of "OTC derivative product" is broad and includes non-deliverable currency forwards, interest rate swaps, credit default swaps and total return swaps.
If an asset manager wishes to apply for the expanded type 9 RA, it must:
i. |
at least one of its responsible officers has been carrying on in Hong Kong or elsewhere an expanded type 9 RA for at least 2 yearswithin the 6 years immediately before the commencement date of the expanded type 9 RA; and |
ii. |
the asset manager is in compliance, or has arrangements in place to ensure compliance, with the relevant provisions in the SFO and the applicable SFC guidelines and codes of conduct. |
Effect of being subject to a "no OTC derivative products management" condition
If an asset manager has applied for the expanded type 9 RA and the SFC subsequently determines to impose a "no OTC derivative products management" condition of its licence, the asset manager can continue to provide a service of managing a portfolio of OTC derivative products for up to 3 months, but solely for the purpose of winding down its clients' OTC derivative positions. The asset manager can apply to the SFC for an extension of this period.
Applying for the new type 11 regulated activity
There is a transitional period of 6 months from the commencement date of type 11 RA during which persons that are not licensed for type 11 RA will not be construed as having contravened the licensing requirement under the SFO.
An asset manager licensed for type 9 regulated activity will not need to apply to be licensed for type 11 RA if:
i. |
it is licensed for the expanded type 9 RA (i.e. not subject to a condition that it must not carry on OTC derivative products management), and |
ii. |
its advising on or dealing in OTC derivatives is solely for the purpose of asset management (expanded type 9 RA). |
If an asset manager provides a discrete service of advising on OTC derivatives or dealing in OTC derivatives (such as providing a central dealing desk for group companies), it may need to apply to be licensed for type 11 RA.
An application for type 11 RA must be made to the SFC within 3 months from the commencement date of type 11 RA and must meet certain conditions. A person that applies and that meets the conditions is deemed to be licensed for type 11 RA from the end of the transitional period of 6 months from the commencement date of type 11 RA until the date of the first to happen of the following:
In addition to making an application to the SFC, the following conditions must be met in order to be deemed licensed for type 11 RA:
An applicant is deemed to be licensed for type 11 RA from end of the transitional period. Such deeming ends on the earliest date on which one of the following events happens:
Effect of SFC refusal of application for type 11 RA
If an asset manager is deemed licensed for the new type 11 RA and the SFC subsequently refuses the asset manager's application, the asset manager can continue to provide type 11 RA services for up to 3 months, but solely for the purpose of winding down its business of advising on or dealing in OTC derivatives. The asset manager can apply to the SFC for an extension of this period.
Subscribe to Publications
Sign up for our regular updates covering the latest legal developments, regulations and case law.